77 Ill. Adm. Code 840.110
Information Required to be Reported
Section 840
Section 840.110 Information
Required to be Reported
a) A facility required to submit information shall report each
cancer incidence and other tumorous and precancerous disease, as specified in
this Section, to the Department.
b) This information to be reported shall be provided in a format
as designated by the Department in electronic form. The electronic form must
comply with the required standard. The facility tumor registrar or other
person designated by the facility shall abstract information from the cancer
patient's record. The information to be reported is divided into seven subject
areas, each containing a particular set of information. The seven subject
areas of the incidence report shall include the following:
1) Reporting Information – type of report being submitted, abstracter
identification code and the date the abstract was submitted.
2) Patient Data and Resident Address − patient's full name
(including maiden name, when applicable and available), Social Security
number, telephone number, and residential address, including street address,
city, county, state, and postal code.
3) Personal Data − patient's birthdate, age, sex, race,
ethnicity, marital status, birthplace, history of tobacco and alcohol usage, history
of occupation and industry, health insurance status and socio-economic status
including, but not limited to, education and income.
4) Diagnosis Data − initial diagnosis date; diagnostic
information; method of diagnosis; primary site; laterality; histology and
behavior code; grade; stage of disease, including clinical and pathological
extent of disease information; existence of other reportable primary diseases
and date of diagnosis; first course cancer-directed therapy; and supporting
text information for all diagnostic procedures, histology, primary site,
staging and treatment.
5) Facility Data − facility identification number provided
by the Department of Public Health, the medical record number, date of
admission, type of reporting source, accession number (if available), case
identification type, discharge date and status, class of case, and name and
Illinois medical license number of attending physician.
6) Follow-Up Data − date of last follow-up or death,
follow-up status, type of follow-up, names of follow-up physicians, cause of
death, whether patient information is incomplete, and names and Illinois
medical license numbers of managing and treating physicians.
7) Text Documentation – description of the primary site,
histology, diagnostic test results, staging, pathology results and treatment
information.
c) Each patient's cancer report form shall be sent within six
months after the date of diagnosis or within four months after the date of
discharge from the reporting facility, whichever is sooner. Reporting
facilities shall report by letter to the Department, each year by July 1, the
status of the completeness of reporting of cancer incidence cases diagnosed
through December of the preceding year.
d) Every hospital, clinical laboratory, ambulatory surgical
treatment center, independent radiation therapy center, independent pathology
laboratory, reference pathology laboratory, nursing home, physician's office
and other diagnostic or treatment facility shall provide the Department or
entities authorized to represent the Department with access to information from
all medical, pathological, and other pertinent records and logs related to
cancer diagnosis, treatment and follow-up for the purpose of quality control,
rapid case ascertainment, patient follow-up and death certificate clearance.
(See Section 10 of the Act.)
e) Every hospital, ambulatory surgical treatment center, clinical
laboratory, independent radiation therapy center, independent pathology
laboratory, reference pathology laboratory, nursing home, physician's office
and other diagnostic or treatment facility shall provide access to information from
all medical, pathological, and other pertinent records and logs related to
cancer diagnosis and treatment for the purpose of patient record review
specified for research studies or for rapid case ascertainment related to
cancer prevention and control conducted by the Department and that have been
approved after appropriate review by the Department for assuring protection of
human subjects. (See 42 CFR 2a.4(a)-(j), 2a.6(a)-(b), 2a.7(a)-(b)(1).)